Q2 sales for the FY2026 August period were 7.8 billion yen, a +0.2% year-over-year increase. Share buyback totaled 528,000 shares, amounting to 990 million yen. The full-year sales forecast is 18 billion yen, up +6.0% year-over-year.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7447","jir_company_name":"Nagaileben Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/7447-20260403-01.pdf","jir_short_summary":"Q2 sales for the FY2026 August period were 7.8 billion yen, a +0.2% year-over-year increase. Share buyback totaled 528,000 shares, amounting to 990 million yen. The full-year sales forecast is 18 billion yen, up +6.0% year-over-year.","jir_summary":"### Overview of Performance\nNet sales for the FY2026 August period Q2 were 7.8 billion yen, nearly flat with a year-over-year increase of +0.2%. Operating income declined by 7.9% year-over-year to 1.381 billion yen. Ordinary income was 1.475 billion yen (down 4.4% YoY), and net income attributable to owners of parent was 1.014 billion yen (down 4.5% YoY). Although the core market experienced a significant revenue decline in Q1, it recovered in Q2 resulting in cumulative sales growth. The overseas market achieved a substantial increase of +35.0%.\n\n### Shareholder Returns and Outlook\nShare buybacks were conducted between November 13 and December 26, 2025, with results of 528,000 shares and 990 million yen against the upper limits of 600,000 shares and 1 billion yen. The full-year net sales forecast is 18 billion yen (up 6.0% YoY), with operating income projected at 4.025 billion yen (up 12.3% YoY). While the current impact from Middle East conditions is limited, risks such as rising crude oil prices and logistics disruptions are being monitored. Price revisions were implemented starting February 2026.","jir_financial_highlights":"Net Sales: 7.8 billion yen (Year-over-Year (YoY) +0.2%)\nShare Buyback Volume: 528,000 shares (Achievement against buyback limit of 600,000 shares)\nShare Buyback Amount: 990 million yen (Achievement against buyback limit of 1 billion yen)\nFull-year Net Sales Forecast: 18 billion yen (Year-over-Year (YoY) +6.0%)\nOperating Income (H1 Results): 1.381 billion yen (Year-over-Year (YoY) -7.9%)\nOrdinary Income (H1 Results): 1.475 billion yen (Year-over-Year (YoY) -4.4%)\nNet Income Attributable to Owners of Parent (H1 Results): 1.014 billion yen (Year-over-Year (YoY) -4.5%)","jir_category":"","jir_hashtags":"#Nagaileben, #EarningsPresentation, #JapaneseStocks","jir_key_figures":"Net Sales (FY2026 August Q2): 7.8 billion yen (Year-over-Year +0.2%)\nShare Buyback Results: 528,000 shares, 990 million yen (Buyback limit: 600,000 shares, 1 billion yen)\nFull-year Net Sales Forecast: 18 billion yen (Year-over-Year +6.0%)","jir_meta_title":"Nagaileben Co., Ltd. FY2026 August Period Q2 Earnings Sales of 7.8 Billion Yen Up 0.2% Year-over-Year","jir_meta_description":"Nagaileben Co., Ltd. FY2026 August period Q2 earnings presentation. Sales of 7.8 billion yen (+0.2% YoY), share buyback of 528,000 shares worth 990 million yen. Full-year sales forecast at 18 billion yen (+6.0%). Includes analysis of Middle East conditions and price revisions.","jir_og_title":"Nagaileben FY2026 August Period Q2 Earnings Announcement","jir_og_description":"Sales of 7.8 billion yen, up 0.2% year-over-year. Share buyback of 528,000 shares, 990 million yen. Full-year forecast at 18 billion yen (+6.0%).","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Millions of Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 2024\\\",\\\"Q2 2024\\\",\\\"Q1 2025\\\",\\\"Q2 2025\\\",\\\"Q1 2026\\\",\\\"Q2 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[2900,\u4e0d\u660e,\u4e0d\u660e,\u4e0d\u660e,2900,4900],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Millions of Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 2024\\\",\\\"Q2 2024\\\",\\\"Q1 2025\\\",\\\"Q2 2025\\\",\\\"Q1 2026\\\",\\\"Q2 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[\u4e0d\u660e,\u4e0d\u660e,\u4e0d\u660e,\u4e0d\u660e,\u4e0d\u660e,1381],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Sales Growth Rate by Market Segment\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Core Market\\\",\\\"Peripheral Market\\\",\\\"Patient Wear\\\",\\\"Overseas Market\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Growth Rate (%)\\\",\\\"data\\\":[1.4,6.4,-9.3,35.0],\\\"backgroundColor\\\":[\\\"#3cba9f\\\",\\\"#e8c3b9\\\",\\\"#c45850\\\",\\\"#8e5ea2\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"price_revision_impact\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Medical Service Fee & Long-term Care Fee Revision Trends (%)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"1992\\\",\\\"1995\\\",\\\"2000\\\",\\\"2005\\\",\\\"2010\\\",\\\"2015\\\",\\\"2020\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Medical Service Fee (Base)\\\",\\\"data\\\":[5.0,4.8,1.5,0.4,1.4,0.6,0.4,0.9,3.1],\\\"backgroundColor\\\":\\\"#f39c12\\\"},{\\\"label\\\":\\\"Medical Service Fee (Drug Price)\\\",\\\"data\\\":[-2.4,-2.0,-1.7,-1.4,-1.4,-1.3,-1.4,-1.0,-0.9],\\\"backgroundColor\\\":\\\"#2980b9\\\"},{\\\"label\\\":\\\"Long-term Care Fee\\\",\\\"data\\\":[0,0,0,3.0,1.2,2.3,0.5,1.6,2.0],\\\"backgroundColor\\\":\\\"#27ae60\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"nurse_care_worker_demand\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Projected Future Demand for Nurses and Care Workers (ten thousand persons)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024\\\",\\\"2040\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Nurses\\\",\\\"data\\\":[169.8,210.1],\\\"backgroundColor\\\":\\\"#3498db\\\"},{\\\"label\\\":\\\"Care Workers\\\",\\\"data\\\":[212.6,272.0],\\\"backgroundColor\\\":\\\"#e74c3c\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":17260,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-39038","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n